Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
出版年份 2020 全文链接
标题
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
作者
关键词
-
出版物
Genome Medicine
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-22
DOI
10.1186/s13073-020-0719-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer
- (2019) Andrea Sartore‐Bianchi et al. ONCOLOGIST
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
- (2019) Thomas Reinert et al. JAMA Oncology
- Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
- (2018) Jelena Belic et al. INTERNATIONAL JOURNAL OF CANCER
- Newly Characterized Motile Sperm Domain-Containing Protein 2 Promotes Human Breast Cancer Metastasis
- (2018) Yaniv Salem et al. INTERNATIONAL JOURNAL OF CANCER
- Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab
- (2018) Erik van Dijk et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
- (2018) Janina Graule et al. Clinical Epigenetics
- POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients
- (2018) Mingqing Wang et al. MOLECULAR CARCINOGENESIS
- Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p
- (2018) Takayuki Arai et al. Molecular Oncology
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
- (2017) Ludovic Barault et al. GUT
- Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients
- (2017) Chiara Bedin et al. INTERNATIONAL JOURNAL OF CANCER
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
- (2017) Viktor A. Adalsteinsson et al. Nature Communications
- Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
- (2016) S. El Messaoudi et al. CLINICAL CANCER RESEARCH
- Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution
- (2016) David R. Braxton et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer
- (2016) Melanie Maierthaler et al. INTERNATIONAL JOURNAL OF CANCER
- Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer
- (2016) Seon Ae Roh et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Near-optimal probabilistic RNA-seq quantification
- (2016) Nicolas L Bray et al. NATURE BIOTECHNOLOGY
- Co-occurrence of MYC amplification and TP53 mutations in human cancer
- (2016) Peter Ulz et al. NATURE GENETICS
- Inferring expressed genes by whole-genome sequencing of plasma DNA
- (2016) Peter Ulz et al. NATURE GENETICS
- Neddylation requires glycyl-tRNA synthetase to protect activated E2
- (2016) Zhongying Mo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating the evaluation of cancer driver genes
- (2016) Collin J. Tokheim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
- (2016) Peter Ulz et al. Nature Communications
- Neddylation requires glycyl-tRNA synthetase to protect activated E2
- (2016) Zhongying Mo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer
- (2016) Wendy Onstenk et al. Oncotarget
- Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma
- (2016) Caixia Cheng et al. GigaScience
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach
- (2015) J. Belic et al. CLINICAL CHEMISTRY
- Pharmacologic resistance in colorectal cancer: a review
- (2015) William A. Hammond et al. Therapeutic Advances in Medical Oncology
- Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor.
- (2015) Paul Mésange et al. Oncotarget
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
- (2014) Sumitra Mohan et al. PLoS Genetics
- Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
- (2013) George Pentheroudakis et al. BMC CANCER
- High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor
- (2013) Gregor Auf et al. BMC CANCER
- Genetic Amplification of the NOTCH Modulator LNX2 Upregulates the WNT/ -Catenin Pathway in Colorectal Cancer
- (2013) J. Camps et al. CANCER RESEARCH
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
- (2013) Ellen Heitzer et al. INTERNATIONAL JOURNAL OF CANCER
- Pan-cancer patterns of somatic copy number alteration
- (2013) Travis I Zack et al. NATURE GENETICS
- Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
- (2013) Ellen Heitzer et al. Genome Medicine
- State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
- (2012) G. Zauli et al. CURRENT MEDICINAL CHEMISTRY
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
- (2012) Luis A. Diaz Jr et al. NATURE
- CDX2 is an amplified lineage-survival oncogene in colorectal cancer
- (2012) K. Salari et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer
- (2011) Christoph Reissfelder et al. BMC CANCER
- Circulating tumour markers can define patients with normal colons, benign polyps and cancers
- (2011) R Mead et al. BRITISH JOURNAL OF CANCER
- Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration
- (2011) F Fan et al. BRITISH JOURNAL OF CANCER
- Determinants of nucleosome organization in primary human cells
- (2011) Anton Valouev et al. NATURE
- Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
- (2011) K. Yonesaka et al. Science Translational Medicine
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
- (2010) Y. M. D. Lo et al. Science Translational Medicine
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started